Lanean...
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
C-reactive protein (at values ≥50 mg/L) is a useful and cheap biomarker for making antibiotic decisions in patients hospitalised for an acute exacerbation of COPD with no additional risk of adverse effect or treatment failure #AECOPD http://bit.ly/342p0Nj
Gorde:
| Argitaratua izan da: | Breathe (Sheff) |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
European Respiratory Society
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885330/ https://ncbi.nlm.nih.gov/pubmed/31803274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0257-2019 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|